Issue of Equity (2848H)
May 25 2011 - 9:42AM
UK Regulatory
TIDMATD
RNS Number : 2848H
Asterand PLC
25 May 2011
For Immediate Release 25 May 2011
Asterand plc
("Asterand" or "the Company")
Issue of Equity
Asterand PLC (LSE: ATD) announces that it has issued and
allotted, conditional only on admission to listing on the UKLA's
Official List and to trading on the London Stock Exchange, a total
of 2,572,140 Ordinary Shares of 5 pence each ("ordinary shares"),
pursuant to the exercise of share options under the Company's Long
Term Incentive Plan and issue of ordinary shares under the
Company's Stock Incentive Plan.
It is expected that the new ordinary shares will be admitted to
listing and to trading at 8:00 a.m. on 1 June 2011.
As a result of this issue of shares and in conformity with the
Financial Services Authority's Disclosure and Transparency Rules,
the Company gives notice that its voting capital consists of
118,484,530 Ordinary Shares of 5 pence each.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, the Company under the FSA's Disclosure and Transparency
Rules.
Contacts:
Asterand plc
Martyn Coombs, Chief Executive Officer Tel: + 44 (0) 1763 211
600 /
+ 1 (313) 263-0960
John Stchur, Chief Financial Officer As above
Buchanan Communications
Lisa Baderoon / Mark Court / Isabel Podda Tel: +44 (0) 20 7466
5000
Daniel Stewart & Company plc
Antony Legge Tel: +44 (0) 20 7776 6566
Martin Lampshire Tel: +44 (0) 20 7776 6550
About Asterand
Asterand plc is a leading supplier of high quality human tissue
and tissue-based services. Our comprehensive approach to human
tissue and research services offers pharmaceutical, biotech and
diagnostic companies the unique opportunity to have one company
meet all of their human biomaterial needs along the continuum of
drug discovery and development. Our mission is to accelerate target
discovery and compound validation and enable pharmaceutical and
biotechnology companies to take safer and more effective drugs into
the market. For more information about Asterand, go to
www.asterand.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEDMGZKFKZGMZM
Bioseek (LSE:ATD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioseek (LSE:ATD)
Historical Stock Chart
From Jul 2023 to Jul 2024
